Showing results (91-100 of 4,121) with videos related to
Sort By:
Pageof 413
European Journal of Pharmacology|January 1, 1976
Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylaseA Dolphin, P Jenner, C D MarsdenBritish Journal of Clinical Pharmacology|January 1, 1983
Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's diseaseP Jenner, M Sheehy, C D MarsdenCiba Foundation Symposium|January 1, 1984
Gamma-aminobutyric acid and basal ganglia outflow pathwaysC Reavill, P Jenner, C D MarsdenNeuropharmacology|December 1, 1982
Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systemsG Luscombe, P Jenner, C D MarsdenEuropean Journal of Pharmacology|August 15, 1979
Changes in dopamine-mediated behaviour during one year's neuroleptic administrationA Clow, P Jenner, C D MarsdenBritish Journal of Pharmacology|March 1, 1987
Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperoneJ Chivers, P Jenner, C D MarsdenEuropean Journal of Pharmacology|February 11, 1986
Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmosetM Nomoto, P Jenner, C D MarsdenBiochemical Pharmacology|August 1, 1985
The effects of dopamine and dopamine agonists on the release of 3H-GABA and 3H-5HT from rat nigral slicesE Kelly, P Jenner, C D MarsdenJournal of Neurology, Neurosurgery, and Psychiatry|September 1, 1979
Relationship between plasma propranolol concentration and relief of essential tremorD Jefferson, P Jenner, C D MarsdenMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
Young onset Parkinson's diseaseN Quinn, P Critchley, C D MarsdenPageof 413